Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00127699 · ClinicalTrials.gov registry record · Phase 1
Triple Dye Plus Alcohol Versus Triple Dye Alone for Newborn Umbilical Cord Care
A Phase 1 study of Infection and Umbilical Cord, sponsored by Penn State University.
- Completed
- Registry status
- Phase 1
- Development phase
- 400
- Enrollment target
- 1
- Study location
NCT00127699 is a Phase 1 study of Infection and Umbilical Cord that has completed, run by Penn State University. The registered enrollment target is 400 participants, below the 717-participant average among 41 other Infection trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00127699, a Phase 1 study of Infection and Umbilical Cord, has completed, sponsored by Penn State University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
In the United States (U.S.) there currently is no standard method of umbilical cord care, resulting in varying practices within and across institutions. These differences may result in an increase in morbidities for newborns such as the formation of umbilical granulomas and increases in acute care utilization. This study will determine which of two common methods of caring for newborn umbilical cords is superior - triple dye, followed by the application of rubbing alcohol, or triple dye alone.
Conditions Studied
Interventions
- PROCEDURE Alcohol swab of umbilical cord
Study Locations (1)
Pennsylvania
- Penn State Milton S. Hershey Medical Center - Hershey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2005-08 |
| Est. Completion | 2007-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00127699
The ClinicalTrials.gov registry entry for NCT00127699 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 717-participant average among 41 other Infection trials with a reported enrollment target (44% lower). The listed sponsor is Penn State University, which has 219 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Infection appearing as the primary indexed condition, and to 1 intervention - of which Alcohol swab of umbilical cord is the first listed.
NCT00127699 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00127699 about?
NCT00127699 is a clinical study titled "Triple Dye Plus Alcohol Versus Triple Dye Alone for Newborn Umbilical Cord Care". In the United States (U.S.) there currently is no standard method of umbilical cord care, resulting in varying practices within and across institutions. These differences may result in an increase in morbidities for newborns such as the formation of umbilical granulomas and increases in acute care u...
What is the current status of trial NCT00127699?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 400 participants. The study started on 2005-08. Estimated completion is 2007-08.
What conditions does trial NCT00127699 study?
This clinical trial studies the following conditions: Infection, Umbilical Cord.
What interventions are being tested in trial NCT00127699?
The interventions under investigation include: Alcohol swab of umbilical cord (PROCEDURE).
Who is sponsoring clinical trial NCT00127699?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00127699 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
NADPH Oxidase Correction in mRNA-transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD)
RECRUITING · Phase 1
-
Pharmacokinetics and Safety of Cefazolin 2g in DUPLEX
COMPLETED · Phase 1
-
Vancomycin Tissue Concentrations by Bier Block or Intravenous Administration
COMPLETED · Phase 1
-
Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation
COMPLETED · Phase 1
-
Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple Myeloma
COMPLETED · Phase 1
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.